Skip to content

A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium

A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium - A retrospective study of neuroendocrine tumor of endometrium

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019710
Enrollment
30
Registered
2015-11-09
Start date
2015-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroendocrine tumor of endometrium

Interventions

None listed

Sponsors

Kansai Clinical Oncology Group
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients diagnosed with neuroendocrine tumor of endometrium between 1995 and 2014.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of chemotherapy and/or radiotherapy for other malignancy. 2) Patients with a severe complication. 3) Patients who have other malignancies.

Design outcomes

Primary

MeasureTime frame
background factors, stage, tratments, pathological findings, prognosis

Countries

Japan

Contacts

Public ContactHarunobu Matsumoto

Faculty of Medicine, Oita University Department of Obstetrics and Gynecology

matumoti@oita-u.ac.jp097-586-5922

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026